Ajooni Biotech: The unaudited financial results for the period ended September 30, 2026
Ajooni Biotech (AJOONI) filed a disclosure titled "The unaudited financial results for the period ended September 30, 2026". The company is valued at about ₹51.29 crore.
What happened
Ajooni Biotech (AJOONI) filed a disclosure with the exchanges on 13 November 2026 at 12:46 PM titled "The unaudited financial results for the period ended September 30, 2026".
Company snapshot
Ajooni Biotech is a micro-cap company, with a market value of about ₹51.29 crore.
The stock last traded at ₹2.83, against a 52-week range of ₹2.68–₹5.5 (48.5% below the high).
Before this filing the shares had moved −3.1% over the month and −26.3% over three months. Average daily turnover over the last 20 sessions was about ₹0.08 crore.
Promoters held 30.53% at the end of Q2 FY27, up 3.64% points from the previous quarter.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 31 | 0.8 | 0.02 |
| Q2 FY26 | 32 | 0.9 | 0.08 |
| Q3 FY26 | 59 | 1.6 | 0.1 |
| Q4 FY26 | 61 | 0.9 | 0.05 |
| Q1 FY27 | 63 | 0.4 | 0.01 |
What history shows
This is not the company's first results disclosure: BCEIE has 2 earlier filings of this kind on record since May 2026.
After those filings, the stock fell 1.8% on average the next trading day and was down 5.5% on average after five days (2 filings with price data).
Market-wide, 11,743 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 43% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 14 Aug 2026 | , the financial results for the period ended Jun 30, 2026. | −1.0% | −2.9% |
| 28 May 2026 | , the financial results for the period ended March 31, 2026. | −2.6% | −8.2% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 13 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.